Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2000
03/09/2000WO2000012718A1 Superoxide dismutase as a vaccine antigen
03/09/2000WO2000012717A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them
03/09/2000WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
03/09/2000WO2000012688A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000WO2000012686A1 Expression systems for functional nucleic acid expression
03/09/2000WO2000012684A2 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus
03/09/2000WO2000012678A2 Staphylococcus aureus genes and polypeptides
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012547A2 Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use
03/09/2000WO2000012542A2 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
03/09/2000WO2000012541A2 Cytotoxic peptides modified by bulky or lipophilic moieties
03/09/2000WO2000012535A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012531A1 Ratc
03/09/2000WO2000012519A1 Phosphoepoxides, method for making same and uses
03/09/2000WO2000012516A1 Phosphohalohydrins, method for making same and uses
03/09/2000WO2000012514A1 Novel compounds
03/09/2000WO2000012509A2 Collections of compounds
03/09/2000WO2000012508A2 Pyrrolbenzodiazepines
03/09/2000WO2000012507A2 Pyrrolobenzodiazepines
03/09/2000WO2000012506A2 Collections of compounds
03/09/2000WO2000012502A1 Pyrroloquinolines for treatment of obesity
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012484A1 Tan-1057 derivatives
03/09/2000WO2000012133A1 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012132A1 Staphylococcal immunotherapeutics via donor selection and donor stimulation
03/09/2000WO2000012131A1 Multicomponent vaccines
03/09/2000WO2000012129A2 Salmonella typhi vaccine compositions
03/09/2000WO2000012128A2 Recombinant subunit vaccine against flaviviral infection
03/09/2000WO2000012125A1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor
03/09/2000WO2000012124A1 Oral vaccine compositions
03/09/2000WO2000012121A1 Method of dna vaccination
03/09/2000WO2000012108A1 Dry extract of henna, method for producing said extract and use of the same
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012101A2 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
03/09/2000WO2000012086A1 Method of mitigating the adverse effects of interleukin-2
03/09/2000WO2000012085A1 Ascorbate-isoquercetin compositions
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000WO2000012067A1 Novel pharmaceutical salt form
03/09/2000WO2000012049A2 A method for the treatment of staphylococcal disease
03/09/2000WO2000012048A2 Carbapenem antibacterial compositions and methods of treatment
03/09/2000WO1999065518A3 Lt and ct in parenteral immunization methods against helicobacter infection
03/09/2000WO1999064570A9 Novel methods and interferon deficient substrates for the propagation of viruses
03/09/2000WO1999064068A9 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
03/09/2000WO1999060859A8 Disinfectant composition
03/09/2000WO1999055873A3 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
03/09/2000DE4090565C2 Rekombinantes Herpesvirus-Pockenvirus-Vakzin A recombinant herpesvirus poxvirus vaccine
03/09/2000DE19838998A1 Neue Naturstoffderivate New natural product derivatives
03/09/2000DE19838809A1 Trockenextrakt aus der Hennapflanze, Verfahren zu dessen Herstellung und dessen Verwendung Dry extract of the henna plant, process for its preparation and its use
03/09/2000CA2777661A1 Multicomponent vaccines
03/09/2000CA2731995A1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2342534A1 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2341986A1 Pyrroloquinolines for treatment of obesity
03/09/2000CA2341775A1 Inducible expression system
03/09/2000CA2341703A1 Salmonella typhi vaccine compositions
03/09/2000CA2341699A1 A method for the treatment of staphylococcal disease
03/09/2000CA2341650A1 Carbapenem antibacterial compositions and methods of treatment
03/09/2000CA2341639A1 Superoxide dismutase as a vaccine antigen
03/09/2000CA2341578A1 Phosphoepoxides, method for making same and uses
03/09/2000CA2341544A1 Method of dna vaccination
03/09/2000CA2341522A1 Novel pharmaceutical salt form
03/09/2000CA2341386A1 Collections of compounds
03/09/2000CA2341352A1 Oral vaccine compositions
03/09/2000CA2341311A1 Staphylococcus aureus genes and polypeptides
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2341177A1 Staphylococcal immunotherapeutics via donor selection and donor stimulation
03/09/2000CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000CA2340788A1 Recombinant nonstructural protein subunit vaccine against flaviviral infection
03/09/2000CA2340462A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000CA2340326A1 Cytotoxic peptides modified by bulky or lipophilic moieties
03/09/2000CA2339947A1 Method of mitigating the adverse effects of interleukin-2
03/09/2000CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
03/09/2000CA2336961A1 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus
03/09/2000CA2335102A1 Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use
03/08/2000EP0984068A2 Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984067A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984013A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1, 3-oxathiolane
03/08/2000EP0983361A1 Bacterial pheromones and uses therefor
03/08/2000EP0983342A1 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
03/08/2000EP0983297A1 New echinocandine derivatives with antimicrobial activity
03/08/2000EP0983293A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/08/2000EP0983271A1 Carbocyclic nucleoside hemisulfate and its use in treating viral infections
03/08/2000EP0983270A1 PROCESS FOR PREPARING 6-$i(O)-MONOESTERS OF CASTANOSPERMINE
03/08/2000EP0983234A1 Leukotriene b 4? derivatives, in particular 7-methylcyclohexyl-ltb 4? antagonists
03/08/2000EP0983087A1 Multivalent vaccine composition with mixed carrier
03/08/2000EP0983079A2 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0983037A1 Antifungal nail lacquer and method using same
03/08/2000EP0696287B1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
03/08/2000EP0672136B1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions
03/08/2000EP0671947B1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses
03/08/2000CN1246867A Helicobacter pylori live vaccine
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
03/08/2000CN1246800A Infectious bursits vaccine
03/08/2000CN1246799A Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
03/08/2000CN1246477A Preparation of N-9 substituted guanine compound
03/08/2000CN1246475A Corticotropin release factors antagonistic agent
03/08/2000CN1246367A Medicine for treating tinea
03/08/2000CN1050129C Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
1 ... 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 ... 1798